default author photo

Dattatreya Mukherjee

Jinan University

MBBS Student

China

  • Jinan University

    • Email
    • Tel: +8613250725953
SCHOLARLY PAPERS

5

DOWNLOADS

348

TOTAL CITATIONS

0

Scholarly Papers (5)

Actions:
Email selected abstracts
1.

Use of JAK STAT Pathway Blocker To Treat COVID19 Patients - The Future of COVID19 Treatment

IJCRT, Volume 8, Issue 6 June 2020
Number of pages: 5 Posted: 01 Jul 2020
Dattatreya Mukherjee, Sufia Imam and Kalyan Kusum Mukherjee
Jinan University, Jinan University and Chittaranjan National Cancer Institute
Downloads 124 (580,653)

Abstract:

Loading...

COVID 19, SARS-COV2 virus, JAK STAT Pathway, Baricitinib and Ruxolitinib

2.

With AMG 510, the Treatment of Non Small Cell Lung Cancer Has Been Changed

Influenced From Asco Annual Conference 2019, IL, Chicago
Number of pages: 7 Posted: 06 May 2020
Dattatreya Mukherjee
Jinan University
Downloads 88 (753,595)

Abstract:

Loading...

K Ras G12C Inhibitor, Achillis Heel, Non-Small Cell Lung, Cancer (NSCLC), GDP, Gtp, Amg 510

3.

Reactive oxygen species (ROS), mitochondrial dynamics & functionality in Parkinson’s disease -A Brief communication

Journal of Applied Biochemistry & Laboratory Medicine. 2021 April ; 2(2): 1-4
Number of pages: 7 Posted: 27 May 2020 Last Revised: 17 Apr 2021
Pallab Chakraborty and Dattatreya Mukherjee
affiliation not provided to SSRN and Jinan University
Downloads 84 (777,583)

Abstract:

Loading...

Reactive oxygen species,Parkinson’s disease, mitochondrial dis-regulation, Treatment

4.

Lenalidomide in Relapsed and Refractory Multiple Myeloma

Number of pages: 9 Posted: 01 Dec 2020
Dattatreya Mukherjee
Jinan University
Downloads 52 (1,041,696)

Abstract:

Loading...

Lenalidomide, Relapse, Refractory, Multiple Myeloma

5.

Recent Advances in PI3K Inhibitor HR+/HER2- Advanced Breast Cancer, A Review Article

ICABEE-BIO-2020
Posted: 29 Sep 2020
Dattatreya Mukherjee and Kalyan Kusum Mukherjee
Jinan University and Chittaranjan National Cancer Institute

Abstract:

Loading...

PI3K, HER+/HER2- Breast Cancer, Alpesilib, Buparlisib, Taselisib